We have shown earlier that heat shock renders human colon cancer cells resistant to curcumin-induced apoptosis, but contribution of individual heat shock proteins (hsps) to this resistance has not been tested. High expression of hsp27 and hsp70, in breast, endometrial, or gastric cancers has been associated with metastasis, poor prognosis and resistance to chemo-or radio-therapy. In this study, SW480 cells were transfected with hsp70cDNA either in sense or antisense orientation and stable clones were selected and tested for their sensitivity to curcumin. The cells were protected from curcumin-induced cell death by hsp70 while the cells harboring antisense hsp70 (Ashsp70) were highly sensitive to curcumin. Curcumin-induced nuclear condensation was less in hsp70 but more in Ashsp70 cells when compared with control vector-transfected cells. Loss of mitochondrial transmembrane potential induced by curcumin was accelerated further by the antisense hsp70 expression and hsp70 restored it partly. Ashsp70 cells released more of cytochrome c, AIF and Smac from mitochondria upon curcumin treatment than the control cells but hsp70 partly prevented the release of AIF but not others. Activation of caspases 3 and 9 induced by curcumin was also inhibited by hsp70 whereas more activation could be seen in Ashsp70 cells although caspase 8 activation was unaffected by changes in hsp70 expression. Curcumin-induced cleavage of PARP and DFF45 was inhibited by hsp70 but enhanced in Ashsp70 cells. The present study demonstrates the potential of hsp70 in protecting SW480 cells from curcumin-induced apoptosis and highlights that silencing the expression of hsp70 with its antisense is an effective approach to augment curcumin-based therapy in cancers that are resistant due to hsp70 expression.
INTRODUCTION
In multicellular organisms, apoptosis or programmed cell death is achieved by at least two independent pathways that are initiated and executed by distinct caspases, a class of cysteine proteases that participates in the dismantling of critical cellular components. For instance, several members of the tumor necrosis factor receptor family such as Fas and tumor necrosis factor receptor-1, recruit procaspase 8 to their cytosolic domains upon ligation to activate caspase 8 that subsequently activates distal caspases 3, 6 and 7 [1] . Another pathway of caspase activation involves mitochondria from which cytochrome c is released in to the cytosol, binds with 1 Apaf-1 (apoptosis protease activating factor-1) and activates caspase 9 in an ATP/dATP-dependent manner [2, 3] . Another proapoptotic protein released from mitochondria along with cytochrome c is Smac (second mitochondria-derived activator of caspase) that functions by relieving the inhibitory function of inhibitor of apoptosis protein that associates with and inhibits caspases [4, 5] . Recently, caspase-independent apoptogenic proteins such as AIF (apoptosis-inducing factor) and endonuclease G have been characterized [6, 7] .
During the past decade, several proteins that promote tumorigenesis by inhibiting apoptosis have been identified in primary tumors, which include antiapoptotic members of the Bcl-2 protein family, heat shock proteins as well as members of the inhibitor of apoptosis protein family [8] . Heat shock proteins (hsps) are highly conserved proteins known to protect cells from adverse environmental, physical and chemical stresses by their ability to prevent protein aggregation and promote the refolding of denatured proteins [9] . The ability of hsps to prevent apoptosis induced by several anticancer drugs also explains how these proteins could limit the efficacy of cancer therapy [10, 11] . Indirect experimental evidences and clinico-pathological studies indicate that hsp70 is the major stress inducible cancer associated antiapoptotic protein [8] . Increased expression of hsp70 has been reported in high-grade malignant breast and endometrial tumors, osteosarcoma and renal cell tumors [10] . Understanding the molecular mechanisms of action of these proteins is necessary to initiate novel modes of rationally and selectively manipulating the sensitivity of cancer cells to therapy [8] .
Curcumin (diferuloylmethane), the major active ingredient of turmeric has been widely used in the treatment of inflammatory disorders for centuries and is also known to possess antiproliferative, anti-mutagenic and anti-carcinogenic properties [12, 13] . Curcumin is known to induce apoptosis in several cancer cells like colon [14] , T Lymphocytes [15] , hepatocarcinoma [16] and breast carcinoma cells [17] . Recently we have shown in human colon cancer cells that mild heat treatment renders them resistant to curcumin-induced apoptosis [18] and in the present study, we developed stable clones of human colon cancer cells (SW480) expressing hsp70 in sense or antisense orientation and tested them for their sensitivity to curcumin treatment. We report that hsp70 expression makes colon cancer cells resistant to curcumin-induced apoptosis by inhibition of processing of caspases and inhibiting the release of AIF and when the expression of hsp70 is silenced, the cells are sensitized to curcumin indicating the potential of such targets in cancer therapy.
EXPERIMENTAL PROCEDURES
Cell Culture-Human colon cancer cell line, SW480, was provided by Ajit Kumar, Indian Institute of Science, Bangalore, India and maintained on DMEM (Life Technologies, Inc.) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Sigma) in an atmosphere of 95% air and 5% CO 2 . Reagents and Antibodies-Curcumin, MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] and DAPI (4,6-Diamidino-2-phenylindole) were procured from Sigma. Rabbit polyclonal antibody to cytochrome c (sc-7159), AIF (sc-5586), PARP (sc-7150), DFF45 (sc-9066), goat polyclonal antibody to Smac (sc-12683) and mouse monoclonal antibody to hsp70 (sc-24) were purchased from Santacruz Biotechnology. Mouse monoclonal antibody to β-actin (A-5441) and all the secondary antibodies were obtained from Sigma. Rabbit polyclonal antibodies to caspase 3 (# 9662) and caspase 9 (# 9502), and a mouse monoclonal antibody to caspase 8 (# 9746) were obtained from Cell Signaling Technology (Beverly, MA). Stable Transfection-SW480 cells grown on 60 mm dishes were transfected with 8 µg of pSVhsp70-tag containing the cDNA for full-length human hsp70 or pcDNA3 hsp70AS, an expression construct for hsp70 in antisense direction, (both the constructs were received from M Jaattela, Danish Cancer Society) by lipofectamine 2000 (Life Technologies, Inc.) as per manufacturer's instructions. The transfected cells were selected by 800 µg /ml of G418 (Life technologies Inc) and clones formed were picked up and maintained separately with 100 µg/ml G418. MTT Assay-Dimethyl thiazol-diphenyltetrazolium bromide (MTT) was used to measure the viability [19] . This assay is based on the conversion of MTT, a soluble tetrazolium salt into insoluble formazan by mitochondrial dehydrogenase enzymes in the viable cells. Hsp70 transfected and vector transfected cells seeded at a density of 5x10 3 cells per well in 96 well plate were allowed to grow for 24h. Subsequently, the cells were incubated with curcumin (25 µM) for 16, 24 and 48h and cell viability was determined by MTT assay. Cell viability was calculated as the amount of dye converted relative to that of untreated control. Isolation of Cytosolic Fraction by Digitonin Lysis Method-Cells (untreated or after treatment) were harvested, washed two times with PBS and the cell pellet was resuspended in digitonin lysis buffer (75 mM NaCl, 1 mM NaH 2 PO 4 , 8 mM Na 2 HPO 4 , 250 mM sucrose, 190 µg/ml of digitonin) containing protease inhibitors and incubated on ice for 5 min. The releasate was centrifuged at 15000 rpm at 4 0 C for 30 min and used for Western blotting as described below using antibodies to AIF, Smac or cytochrome c and appropriate secondary antibodies. Western Blotting-Cells were harvested, washed thrice in PBS, and lysed in RIPA lysis buffer (50 mM Tris-Cl (pH 7.4), 1% NP-40, 40 mM NaF, 10 mM NaCl, 10 mM Na 3 VO 4 , 1mM phenylmethylsulfonyl fluoride, and 10 mM dithiothreitol and 1 µg /ml each of leupeptin and aprotinin). The cell lysates (50 µg of protein) were loaded on to SDS-PAGE and the separated proteins were transferred to nitrocellulose membrane by wet transfer method using Bio-Rad electro-transfer apparatus. After blocking with 10% non-fat milk in Tris buffered saline containing 0.2% Tween 20, the membrane was incubated with a primary antibody followed by an alkaline phosphatase conjugated secondary antibody and the protein bands were visualized by 3,3'-diaminobenzidine/H 2 O 2 mixture (Sigma). Determination of Mitochondrial Membrane Potential (∆Ψm)-Briefly, the cells grown in 96 well plates with or without treatment were washed with serum free medium and stained with a cationic dye called Mitosensor (ApoAlert mitochondrial membrane sensor kit, Clonetech) as per the manufacturer's protocol and analyzed by fluorescence microscopy using a band-pass filter. The dye is taken up in the mitochondria, where it forms aggregates that exhibit intense red fluorescence. However, once ∆Ψm is lost, Mitosensor cannot accumulate in the mitochondria and stays in the cytosol as monomer with green fluorescence. Cells showing loss of ∆Ψm (green) were expressed in percentage by counting the number of red and green cells in at least three different fields by two different investigators. Assessment of Chromatin Condensation-The cells were grown on 12 mm cover slips and exposed to 25 µM of curcumin in sub confluent stage for 24h. The monolayer of cells were washed in PBS and fixed with 3% paraformaldehyde for 10 min at room temperature. The fixed cells were permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature and incubated with 0.5 µg /ml of DAPI for 5 min. The apoptotic nuclei (intensely stained, fragmented nuclei and condensed chromatin) were scored in percentage from 200-300 cells/sample with at least two investigators using a fluorescent microscope (Nikon TE 300). Immunofluorescent Staining-The cells grown on glass cover slips, after appropriate treatments, were fixed and permeabilized as before and then incubated with the respective primary antibody for overnight. After extensive washing with Tris buffered saline containing 0.2% Tween 20, the cells were incubated with FITC (fluorescein isothiocyanate) conjugated secondary antibody at 1:50 dilution for 45 min in the dark. The cover slips were mounted with 50% glycerol-PBS, and viewed under fluorescent microscope and photographed. Determination of Caspase Activities-The subconfluent cells growing on 100 mm dishes treated with curcumin 25 µM for 8, 16 or 24h or left untreated were assayed spectrofluorimetrically for the enzymatic activities of caspase 3, caspase 9 and caspase 8 [20] . Briefly, the whole cell lysate was incubated with 50 µM of fluorimetric substrates of caspase 3 (Ac-DEVD-AFC) or caspase 9 (Ac-LEHD-AFC) or caspase 8 (Z-IETD-AFC) in a total volume of 500 µl of reaction buffer [50 mM HEPES-KOH, pH 7.0, 10% glycerol, 0.1 % 3-(cholamidopropyl)-dimethylammonio-1-propane sulfonate, 2 mM EDTA, 2 mM dithiothreitol] at 37 0 C for 1 h. The released AFC was quantitated using a spectrofluorimeter (Perkin Elmer, LS-50 B) with the excitation and emission wavelengths of 405 and 500 nm, respectively. Values of relative fluorescence units released per milli gram of protein were calculated. Further the cleaved fragments of caspase 3, 9 and 8 were detected by Western blotting using specific antibodies that detect the intact mother band as well as the corresponding cleaved fragments as described earlier.
RESULTS

Ectopic Expression of Hsp70 Renders SW480 Cells Resistant, Whereas that of Ashsp70
Sensitizes them, to Curcumin-induced Cytotoxicity-To understand whether hsp70, known to possess antiapoptotic properties, could regulate curcumin-induced apoptosis, SW480 human colon cancer cells were first stably transfected with pSV-hsp70-tag (with hsp70 cDNA in sense orientation) or pcDNA3 hsp70AS (with hsp70 cDNA in antisense orientation) constructs. The relative expressions of hsp70 assessed by Western blotting in different G418-resistant clones were quantitated using 'Quantity One' software for image analysis (Bio-Rad) after normalizing for the value of loading control (β-actin intensity). The vectors, pSV-tag and pcDNA3, contain neomycin resistant genes and we used one of them (pcDNA3) as a control and when compared to these pcDNA3 vector-transfected cells (neo), all the hsp70-transfected clones expressed higher level of hsp70 (Fig. 1A) and similarly all the three Ashsp70-transfected clones showed lower levels of hsp70 compared to neo cells (Fig. 1B) . A clone of hsp70 cells that expressed eight-fold higher level of hsp70 (clone 1) (Fig. 1A ) and the Ashsp70 clone 1 that showed very low expression of hsp70 (Fig. 1B) were used for subsequent experiments. Then neo, hsp70 or Ashsp70 cells were incubated with 25µM curcumin for 16, 24 or 48h and the cell viability was analyzed by MTT assay. Upon treatment with curcumin, the mean viability values for neo cells were 66, 53 and 35% over the untreated control for 16, 24 and 48h, respectively, indicating the increase in cytotoxicity by curcumin over this time period (Fig. 1C) . In hsp70 cells, viabilities were much better with mean values being 94 (p < 0.038), 82 (p < 0.036) and 68% (p < 0.013) and in contrast, only 43 (p < 0.004), 30 (p < 0.008) and 20% (p< 0.005) of Ashsp70 cells survived upon curcumin treatment for the same time intervals (Fig. 1C) . These data suggest that hsp70 cells resist curcumin treatment whereas neo and more effectively the Ashsp70 cells are sensitive to curcumin-induced cell death.
Curcumin Induces Nuclear Condensation Effectively in Neo and Ashsp70 Cells But Not in Hsp70
Cells-To know whether the survival of hsp70 cells was associated with inhibition of apoptosis, the neo, hsp70 or Ashsp70 cells were exposed to 25 µM curcumin for 24h and the chromatin condensation was analyzed by DAPI staining. All the untreated samples from neo, hsp70 or Ashsp70 cells showed uniform diffuse staining with DAPI but, upon treatment with curcumin, 65% of neo, 35% (p< 0.022) of hsp70 and 93% (p<0.011) of Ashsp70 cells showed condensed nuclear morphology (Fig. 2.A and B) . These results indicate that curcumin-induced cytotoxicity involves nuclear condensation characteristic of apoptosis and ectopic expression of hsp70 promotes survival of SW480 cells whereas down regulating hsp70 sensitizes them to curcumininduced apoptosis.
Ashsp70 Expression Augments Curcumin-induced Loss of ∆Ψ m and Hsp70 Expression Partly
Restores It-Loss of ∆Ψ m is one of the earliest events of curcumin-induced apoptosis observed by us in SW480 cells [18] . Hence, we analyzed whether hsp70 expression or its down regulation could play a protective role by altering curcumin-induced loss of ∆Ψ m . Untreated neo, hsp70 and Ashsp70 cells showed granular red fluorescence indicating integrity of ∆Ψ m (Fig. 3A) . However, upon exposure to 25µM curcumin for 24h, only 23% of neo, 32% (p < 0.075) of hsp70 and 10% (p<0.012) of Ashsp70 cells retained the ∆Ψ m (Fig. 3B) . These data indicate that the expression of hsp70 partly restores the ∆Ψ m loss induced by curcumin, but curcumin-induced ∆Ψ m loss is more in Ashsp70 cells.
Hsp70 Partially Prevents Curcumin-induced AIF Release, But Not that of Cytochrome c and Smac From Mitochondria While AsHsp70
Enhances Their Release-Cytochrome c, Smac and AIF are mitochondrial proteins that are safely stored within the intermembrane space of mitochondria in intact cells [21] . We have tracked these molecules with corresponding primary antibodies and FITC conjugated secondary antibodies after 24h of curcumin (25 µM) treatment. Neo control, hsp70 control and Ashsp70 control cells showed granular mitochondrial staining for cytochrome c, Smac and AIF (Fig. 4A) . Upon curcumin treatment, neo and Ashsp70 cells showed diffuse pattern of staining for cytochrome c, Smac and AIF indicating their release from mitochondria and curcumin-induced release of all the three molecules was relatively more in Ashsp70 cells (Fig. 4A) . Curcumin-induced release of cytochrome and Smac was also noticed in hsp70 cells but the AIF release was not complete (Fig. 4A) . The cytoplasmic release of cytochrome c, Smac and AIF was analyzed further by Western blotting of digitonin-lysed samples treated with or without curcumin. Fig. 4B shows that upon curcumin treatment, neo cells released all the three molecules whereas hsp70 cells released cytochrome c and Smac but the release of AIF was partial while the β-actin levels were unchanged with or without curcumin. Upon curcumin treatment, the release of cytochrome c, Smac and AIF was more in Ashsp70 than neo cells (Fig.  4C ). These data show that hsp70 expression partially prevents curcumin-induced release of AIF without inhibiting the release of cytochrome c and Smac from mitochondria and the expression of antisense hsp70 sensitizes SW480 cells to release more amounts of these molecules upon curcumin treatment.
Hsp70 Inhibits Curcumin-induced Activation of Caspases 3 and 9 But Not 8 Whereas Ashsp70
Potentiates the Effects of Curcumin-Cytochrome c released in to the cytosol is known to bind Apaf-1 and procaspase 9 leading to the activation of caspases 9 and 3 [22] . In order to understand whether changes in hsp70 expression interfere with the activation of caspases during curcumin-induced apoptosis, the processing of procaspases 9, 3 and 8 was assessed using specific spectrofluorimetric substrates as well as immunodetection of cleaved fragments of these caspases. As can be seen from Fig. 5A , caspase 9 was activated with increase in time of incubation with curcumin in neo and more effectively in Ashsp70 (p < 0.001-0.0001) cells whereas hsp70 cells exhibited lower level of activity that did not change throughout the experimental period (p < 0.001 -0.0001). In Western blot analysis, the cleaved fragments (37kDa) indicating the activation of caspase 9 by curcumin were visible in neo and Ashsp70 cells but not in hsp70 cells (Fig. 5B) . Similarly caspase 3 activation by curcumin increased with time in neo and again more efficiently in Ashsp70 (p < 0.001-0.002) cells but hsp70 cells exhibited lower activation that remained unchanged when analyzed by spectrofluorimetric method ( p< 0.002-0.001) (Fig. 5C ). These results were further confirmed by Western blotting that showed the cleaved fragment of procaspase 3 only in neo and Ashsp70 cells but not in hsp70 cells when induced by curcumin for the time periods shown (Fig. 5D) . When curcumin-induced activation of caspase 8 was assessed in neo, hsp70 and Ashsp70 cells using a specific fluorimetric substrate, all of them showed increased activity with increase in time (Fig. 5E) . Similarly, the cleaved fragment could be seen in all the three cells treated with curcumin throughout the experimental period (Fig. 5F ) suggesting that activation of caspase 8 by curcumin is not affected by changes in hsp70 expression. Both fluorimetric as well as Western blotting methods supported the finding that hsp70 remarkably reduced the activation of procaspase 9 and 3 and not 8. The experimental results substantiate that hsp70 predominantly blocks apoptosis downstream of mitochondrial release of cytochrome c especially reducing the processing of caspase 9 and subsequent caspase 3 processing and activation of these caspases was potentiated in Ashsp70 compared to neo cells.
Hsp70 Blocks Curcumin-induced Cleavage of PARP and DFF45 But Ashsp70 Enhances the
Effects of Curcumin-PARP and DFF45 are two important cellular proteins necessary for maintaining cellular integrity that are cleaved and rendered inactive during apoptosis. As shown in Fig. 6A , curcumin cleaved 116 kDa PARP in to a fragment (85 kDa) after 16h and by 24h the intensity of the cleaved fragment increased in neo cells whereas in hsp70 cells cleaved fragment was not visible up to 16h although a very faint 85 kDa band could be seen at 24h. In contrast, cleaved fragment could be observed along with the disappearance of 116 kDa PARP band in Ashsp70 cells treated with curcumin for 16 or 24h (Fig. 6A) . Similarly, DFF45 cleavage was observed in neo cells as early as 16h and continued at 24h upon treatment with curcumin whereas in hsp70 cells only a faint band was visible at 24h and in contrast, Ashsp70 cells showed DFF45 cleavage for all the time periods of this experiment (Fig. 6B) . These results show that hsp70 expression suppresses curcumin-induced apoptosis predominantly by preventing the processing of caspases and by preventing the cleavage of caspase substrates like PARP and DFF45. A model showing the effects of hsp70 on curcumin-induced apoptosis is shown in Fig.7 .
DISCUSSION
Triggering apoptosis in cancer cells is the prominent mechanism by which most anticancer agents act and failure to elicit it not only leads to the development of tumors but also increases their resistance to therapy [23] . High expression of hsps especially hsp27 and hsp70, in breast, endometrial, or gastric cancer has been associated with metastasis, poor prognosis and resistance to chemo-or radio-therapy [24] . We have shown earlier that heat shock renders human colon cancer cells, SW480 and SW620, resistant to curcumin-induced apoptosis, but the potential contribution of any of the individual hsps to this resistance has not been tested [18] . The present study demonstrates the potential of hsp70 in protecting human colon cancer cells from curcumininduced apoptosis and highlights that silencing the expression of hsp70 with its antisense is an effective approach to augment curcumin-based therapy. Over-expression of hsp70 was shown to confer tumorigenicity and resistance to the cytotoxic effects of tumor necrosis factor, staurosporine and doxorubicin [10, 25] . Selective depletion of hsp70 by its antisense alone was sufficient to kill human breast cancer cells independent of caspases and apoptotic stimuli without affecting the survival of non-tumorigenic breast epithelial cells [11] . Inhibition of curcumininduced activation of caspases and partly blocking the release of AIF by hsp70 suggests that it interferes with caspase-dependent and independent pathways induced by curcumin in human colon cancer cells.
Consistent with our results showing curcumin-induced release of AIF, others have shown the involvement of AIF-mediated large scale DNA fragmentation in response to curcumin [26, 27] . Since the release of cytochrome c or Smac is unaffected by hsp70 expression in human colon cancer cells it suggests that hsp70 is acting downstream of cytochrome c release whereas Bcl-2 prevents the release of AIF and cytochrome c from the mitochondrion [6, 21, 28] . Our results support the notion that the loss of ∆Ψ m and the release of cytochrome c, AIF and Smac from mitochondria are separate events [29, 30] . Accelerated loss of ∆Ψ m and enhanced release of AIF, cytochrome c and Smac upon curcumin treatment in Ashsp70 cells may be secondary to increased caspase activation [31] . Translocation of cytochrome c from mitochondria to cytosol is also said to occur very early (before the ∆Ψ m loss) during the apoptotic process [32] . Our results showing inhibition of curcumin-induced activation of both caspases 9 and 3 in hsp70 cells and the enhanced activation of these caspases in Ashsp70 cells are supported by the report that unlike Bcl-2, hsp70 interacts directly with Apaf-1 with subsequent inhibition of cytochrome c mediated oligomerization of Apaf-1 and processing of procaspase 9 [21, 33] . The reduced cleavage of caspase 3 substrates like PARP and DFF45 in hsp70 cells together with their increased cleavage by the selective depletion of hsp70 indicates a role for hsp70 to inhibit apoptosis downstream of caspase 3 activation [25] . However, hsp70 can also prevent cell death in conditions in which caspase activation doesn't occur i.e. after the inactivation of Apaf-1 gene, suggesting that caspase inhibition may not be the sole mechanism behind the survival effect of hsp70 [34] .
Since hsp70 prevented the processing of caspase 9 and caspase 3 in human colon cancer cells in the present study, subsequent release of AIF probably required active caspases and in agreement with this it has been reported that release of AIF is downstream of cytochrome c release and requires active caspase-3 [35] . It appears that there will be an initial loss of AIF from mitochondria along with the release of Cyt c or Smac independent of caspases. However, subsequent mitochondrial release of AIF may require require active caspases, an event likely to be blocked in hsp70 overexpressing cells. This notion is further substantiated by the accelerated release of AIF in Ashsp70 cells. Both immunoblot and immunofluorecence microscopic experiments substantiated the findings. Failure of hsp70 to prevent completely the release of AIF may be the reason for not getting complete protection in hsp70 overexpressing cells by MTT assay. On isolated mitochondria, Bax (a proapoptotic member of the Bcl-2 family) causes the release of cytochrome c, but not of AIF, and it has been hypothesized that the association of AIF with the mitochondrial inner membrane can account for its lack of release upon Bax-mediated outer membrane permeabilization [35] However, the actual mechanism behind the selective retention of AIF within the mitochondria in hsp70 cells is not known and contradictory results from different groups makes it difficult to discern whether AIF release depends upon different cell types or stimuli and if it occurs in a caspase-dependent or independent fashion [36] .
Although curcumin induces both the receptor-and mitochondria-mediated pathways of apoptosis [18, 37, 38] hsp70-mediated survival does not appear to inhibit receptor-mediated pathway, as curcumin-induced cleavage of procaspase 8 remains unaffected by changes in hsp70 expression. Curcumin (facilitated by its hydrophobic nature) is said to induce oligomerisation and aggregation of Fas receptor in the cell membrane to activate caspase 8, but to induce cell death further events such as the cleavage of Bid, release of cytochrome c and activation of other caspases (inhibited by hsp70) are necessary [39, 40] . Our results suggest that the potential drugs like curcumin may not be effective to eliminate chemo resistant cancers that overexpress hsp70, but down regulation of hsp70 remarkably sensitizes the human colon cancer cells to apoptosis induced by curcumin and interventional approaches to reduce the expression of hsp70 offer novel ways to eliminate such cancers. FIG.1 . Establishment of stable clones expressing hsp70 or its antisense, and changes in cell viability induced by curcumin. A, SW480 cells were stably transfected with pSV-hsp70-tag using lipofectamine 2000 as per manufacturer's instructions (Life Technologies, Inc.) and whole cell extracts prepared from three different G418-resistant clones were analyzed for hsp70 expression by Western blot (10% gel) using a mouse monoclonal antibody as described under Experimental Procedures. B, SW480 cells were transfected with pcDNA3 hsp70 AS and G418-resistant clones were analyzed for hsp70 expression by Western blot as described above. For the above experiments, cells transfected with the empty vector pcDNA3 served as control (neo) and β-actin as loading control and they were repeated at least two times with similar results. C, SW480 cells (neo, hsp70 or Ashsp70) grown on 96 well plates were exposed to curcumin (25  µM) were assessed for the activation of caspase 9 using a fluorimetric substrate (Ac-LEHD-AFC) in a reaction buffer at 37 0 C for 1h as described under Experimental Procedures. B, Caspase 9 activation was also assessed by Western blotting as described under the Experimental Procedures. C, Activation of caspase 3 by curcumin at the indicated periods of time was determined by using a fluorimetric substrate of caspase 3 (Ac-DEVD-AFC) as described under the Experimental Procedures. D, Caspase 3 activation was confirmed by Western blot analysis as described above. E, Caspase 8 activation assessed by spectrofluorimetric methods substrate (Z-IETD-AFC) was essentially same as described above. F, Western blot was used to assess caspase 8 activation. All these experiments were repeated at least two times with similar results and the error bars denote standard deviation.
FIGURE LEGENDS
FIG. 6.
Curcumin-induced Cleavage of PARP and DFF45. A, Lysates (60µg of protein) prepared after treating the cells with or without curcumin (25 µM) for the indicated time periods were analyzed for PARP with a specific polyclonal antibody as described under Experimental Procedures. B, Western blotting was carried out for the detection of DFF45 and its cleaved fragment using a specific polyclonal antibody as described above and these experiments were repeated two times with similar results .  FIG. 7 . A model depicting the role of hsp70 in curcumin-induced apoptosis. Curcumin induces apoptosis by both receptor-and mitochondria-mediated pathways. Hsp70 blocks apoptosis by inhibiting curcumin-induced activation of caspases 9 and 3 and also the caspase 3 mediated cleavage of DFF45 and PARP. The release of AIF is also partly prevented by hsp70. 
